HDAC2 and glioblastoma: Clinical retrospective studies have shown that the antiepileptic drug sodium valproate, alone or in combination with radiotherapy or chemotherapy, can suppress seizure activity and extend the survival of GBM patients[23, 31], which may be explained by its additional pharmacodynamic properties, particularly its HDAC2 inhibition.